16.08.2020 Views

kupdf.net_manual-practico-medicina-estetica

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Hipercromías y melasma

mantenerse los resultados recurriendo al

empleo de productos blanqueadores y a

una adecuada fotoprotección.

Lucía López Agüero

lucyk@infovia.com.ar

R eferencias bibliográficas

1. Fitzpatrick TB, Ortonne JP. Trastorno de

los melanocitos en Fitzpatrick Dermatología en

Medicina General de fP Freedberg, Eisen, Wolff,

Austen, Goldsmith, Katz. Cap. 88, pp 920-2005,

Editorial Panamericana ISBN: 950-06-0733-6

2. Cordero AA. Biología de Piel, estructura y fimckmes.

Ed Médica Panamericana1996 Pp 110. ISBN: 95006-0415-9

3. Bolognia JL, Jorizzo JL, Rapini R. Melanocyte

biology en Dermatology de JL Bolognia, Seth J

Orlow. 2008, Cap 64 pp 901-912 Elsevier Limited.

ISBN: 9781416029991

4. http://www.camaracecep.com.arlnotaclase.html

5. Luger TA, Scholzen T, Grabbe S. The rol o f

alpha-melanocyte-stimulating hormone in cutaneus

biology. J Invest Dermatol Symp Proc.l997;2:87-93

6. Spencer JD, Chavan B, Marles LK, Kauser S,

Rokos H, Schallreuter KU. A novel mechanism in

control o f human pigmentation by {betaj-melanocytestimulating

hormone and 7-tetrahydrobiopterin. J

■Endocrinol. 2005 Nov;187(2):293-302

7. Sánchez-Mds J, Hahmann C, Gerritsen I,

García-Borrón JC, Jiménez-Cervantes, C. Agonistindependent,

high constitutive activity ofthe human

melanocortin 1 receptor. Pigment Cell Res. 2004

Aug;17(4):386-395.

8. García-Borrón JC, Sánchez-Laorden BL, Jiménez-

Cervantes, C. Melanocortin-1 receptor structure and

jündional legulation. Pigment Cell Res. 2005Dec; 18(6)393-410

9.http://books.google.com.ar/books?id=imPn2IRlc94

C&pg-PA37&lpg=PA37&’dq=proteina+P+y+mela

nogenesis&source=web&ots=BCu-xTFJMO&sig=_

dkFgcKvTv7BvjjPNjsqkwkgvM&hl=es&sa=X&oi=book_

result&resnum=l &ct=result

10. Jimbow K, Gómez PF, Toyofuku K, Chang D,

Miura S, Tsujiya H, Park JS. Biological role o f

tyrosinase related protein and its biosíntesis ans

transportfrom TGN tostagel melanosome, late endosóme,

through gene transfection study. Pigment Cell Res.

1997 Aug; 10(4):206-213

11. Mishima M. Molecular and biological control

o f melanogenesis through tyrosinase genes and

intrinsic and extrinsic regulatory factors. Pigment

Cell Res. 1994 Dec; 7(6):376-387.

12. Schwahn DJ, Xu W, Herrín AB, Bales

ES, Medrano EE. Tyrosine levels regúlate the

melanogenic response to alpha-melanocytestimulating

hormone in human melanocytes:

implications for pigmentation and proliferation.

Pigment Cell Res. 2001 Feb;14(l):32-39.

13. Bleehen SS, Ebling FJG, Champion RH,

Disorders ofskin colours. In Champion RH, Burton

JL, Ebling FJG, eds, Text book o f Dermatology 5th

edn. Blackwell: Oxford 1992. pp 1593-1618

14. Lee J, Jung E, Lee J, Hidi S, Boo YC, Hyun CG,

Kim YS, Park D. Mechanisms o f melanogenesis

inhibition by 2,5-dimethyl-4-hydroxy-3(2H)-furanone.

Br J Dermatol. 2007 Aug;157(2):242-248

15. Gilchrest BA, Fitzpatrick TB, Anderson RR,

Parrish JA. Localization ofm elanin pigmentation in

the skin with Wood s lanrp. Brj DermatoL 1977,96:245-248.

16. Hassan I, Kaur 1, Sialy R, Dash RJ, Hormonal

milieu in the maintenance o f melasma in fértil

women. J Dermatol. 1998 Aug;25(8):510-512.

17. Sialy R, Hassan I, Kaur I, Dash RJ. Melasma in

men: a hormonal profile. J Dermatol. 2000 Jan;27 (l):64-65

18. Kurita M, Kato H, Yoshimura K. A therapeutic

strategy based on histological assessment o f

hyperpigmented skin lesions in Asians. J Plast

Reconstr Aesthet Surg. 2008 May 2. Epub ahead of

print MID: 18456589 PubMed-as supplied bypublisher

19. Kim EH, Kim YC, Lee ES, Kang HY. The

vascular characteristics o f melasma. J Dermatol Sci.

2007 M ay;46(2):lll-116.

20. Bolognia JL, Jorizzo JL, Rapini R. Melanocyte

biology. Disorders o f hyperpigmentation, en

Dermatology vol 1. de Mary Wu Chang. Second ed,

Cap. 66 pp 939-954 2008 Elsevier Limited ISBN:

9781416029991

21. Bhor U, Pande S. Scoring systems in dermatology.

Indian J Dermatol Venereol Leprol 2006 72:315-21.

22.Kimbrough-GreenCK,GriffithsCE,FinkelLJ,Hamilton

TA, Bulengo-Ransby SM, Ellis CN, Voorhees JJ. Topical

retinoic acid (tretinoin) for melasma in black patients. A

vehide-coi ibdled cliniai trici Airh Dermatol 1994;130:727-733.

23. Piqueiv-Martíh J, Piquero-Casals J. Diagnóstico y

tratamiento del melasma. Piel 2000; 15:182-187.

24. Ilya Petrou. Treating melasma: Copper bromide láser

effectively targets vasculature. Dermatology Times. Nov

1, 2008.

115

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!